Krishnan, Navasona <br/><br/>
PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.  [electronic resource] 

 -  The Journal of clinical investigation  Aug 2015 
 - 3163-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI80323  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain-Derived Neurotrophic Factor--genetics<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Male<br/>Methyl-CpG-Binding Protein 2--genetics<br/>Mice<br/>Mice, Inbred CBA<br/>Mice, Mutant Strains<br/>Phosphorylation--drug effects<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1--antagonists & inhibitors<br/>Receptor, trkB--genetics<br/>Rett Syndrome--drug therapy<br/>Signal Transduction--drug effects